U.S. Building Stock News

Alpha Metallurgical Resources, Inc. ( NYSE:AMR ) shares have retraced a considerable 26% in the last month, reversing a...

You may think that with a price-to-sales (or "P/S") ratio of 0.8x Repay Holdings Corporation ( NASDAQ:RPAY ) is a stock...

Despite an already strong run, StoneX Group Inc. ( NASDAQ:SNEX ) shares have been powering on, with a gain of 26% in...

Some Bank First Corporation ( NASDAQ:BFC ) shareholders may be a little concerned to see that the Director, Steven...

To the annoyance of some shareholders, Cemtrex, Inc. ( NASDAQ:CETX ) shares are down a considerable 44% in the last...

To the annoyance of some shareholders, CISO Global Inc. ( NASDAQ:CISO ) shares are down a considerable 29% in the last...

We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...

Why the new investigation matters for Quanex Building Products (NX) shareholders An investigation into Quanex Building Products (NX) has been launched after allegations that management did not fully disclose underinvestment and equipment issues at its Tyman Mexico facility, raising fresh questions about governance and integration execution. See our latest analysis for Quanex Building Products. Quanex Building Products’ recent 30 day share price return of 22.11% and 90 day share price return...

Ingersoll Rand (IR) has wrapped up FY 2025 with fourth quarter revenue of US$2.1 billion and basic EPS of US$0.68, alongside trailing twelve month revenue of US$7.7 billion and EPS of US$1.46 that reflect the impact of a one off loss on profitability. The company has seen revenue move from US$1.90 billion and EPS of US$0.57 in Q4 2024 to US$2.1 billion and EPS of US$0.68 in Q4 2025, while trailing net margin has compressed from 11.6% to 7.6% as that US$273.4 million one time hit flows through...

Essent Group (ESNT) has posted its latest FY 2025 numbers, with Q3 total revenue at US$311.8 million and basic EPS of US$1.69, backed by net income of US$164.2 million. The company has seen quarterly revenue range between US$312.9 million and US$344.4 million over the last six reported periods, while basic EPS has moved between US$1.60 and US$1.95 over the same stretch, giving investors a clear view of how the top line and EPS have tracked together through recent quarters. Set against a...

In its most recent quarter ended December 31, 2025, STERIS plc reported higher sales of US$1,496.2 million and net income of US$192.9 million, alongside completing a US$350.6 million share repurchase program totaling 1,507,158 shares since May 2023. The combination of rising earnings per share and ongoing margin pressure from tariffs and inflation highlights a tension between growth in profitability metrics and the cost environment facing STERIS. We’ll now examine how STERIS’s margin...

Callaway Golf (CALY) has just posted its FY 2025 third quarter results, with revenue of US$934 million and a basic EPS loss of US$0.08, setting a cautious tone around profitability. Over the past few quarters, revenue has moved from US$1,157.8 million in Q2 2024 to US$1,092.3 million in Q1 2025, US$1,110.5 million in Q2 2025 and now US$934 million in Q3 2025. Basic EPS has swung from a loss of US$8.23 in Q4 2024 to profits of US$0.34 in Q2 2024 and US$0.11 in Q2 2025, before slipping back...

If you are wondering whether Zai Lab's current share price reflects its real worth, you are not alone. This article walks through what the numbers suggest about value. The stock last closed at US$20.03, with returns of 11.3% over 7 days, 2.1% over 30 days, 15.6% year to date, but a 30.9% decline over 1 year, 46.4% over 3 years and 88.6% over 5 years. These mixed returns sit against a backdrop where investors have been watching Zai Lab as part of the broader pharmaceuticals and biotech space,...

How Moderna's Latest Numbers Set the Stage for Its Next Chapter Moderna (MRNA) has just posted third quarter FY 2025 revenue of US$1,016 million with a basic EPS loss of US$0.51 and net income loss of US$200 million, as its mRNA platform continues to move through an investment heavy phase. The company has seen quarterly revenue move from US$966 million in Q4 2024 to US$108 million in Q1 2025, US$142 million in Q2 2025 and then US$1,016 million in Q3 2025. Over the same stretch, basic EPS...

Federal Home Loan Mortgage (FMCC) FY 2025 earnings snapshot Federal Home Loan Mortgage (FMCC) has wrapped up FY 2025 with fourth quarter revenue of US$5.7 billion, a basic EPS loss of US$0.002 per share and net income excluding extra items showing a loss of US$7 million, against prior year fourth quarter revenue of US$6.2 billion, basic EPS of US$0.011 per share and net income of US$37 million. Over the past few quarters, revenue has ranged from US$5.1 billion to US$5.7 billion in FY 2025,...

Insperity (NYSE:NSP) is rolling out major cost-cutting measures, including a reduction in non-sales staff and tighter expense controls, in response to profitability pressure. The company is targeting a $20 million cut in operating expenses while pushing ahead with HRScale, its new mid-market HR platform developed with Workday. HRScale is aimed at thousands of employees across small and mid-sized businesses, signaling a shift in how Insperity serves the mid-market HR segment. For investors...

Pilgrim's Pride is expanding its Just Bare brand and planning new growth projects as it responds to current industry conditions. The company is preparing investments in a new Georgia facility and increasing capital deployment in Mexico. These moves come while Pilgrim's Pride manages challenges such as commodity price swings and pressure on margins. Pilgrim's Pride, traded as NasdaqGS:PPC, is pushing ahead with brand and capacity expansion while its shares trade around $43.32. Over the past...

Protagonist Therapeutics submitted NDAs for Icotrokinra in plaque psoriasis and Rusfertide in polycythemia vera, advancing two late stage drug candidates. The company is progressing Phase 3 trials in partnership with large pharmaceutical companies, including Johnson & Johnson and Takeda. These filings and trial advances represent fresh milestones for NasdaqGM:PTGX that have not yet been widely discussed in the market. Protagonist Therapeutics, trading on NasdaqGM:PTGX, is drawing fresh...

Roku’s FY 2025 results reset the profit story Roku (ROKU) closed out FY 2025 with Q4 revenue of about US$1.4 billion and basic EPS of US$0.54, capping a year in which trailing twelve month revenue reached roughly US$4.7 billion and EPS landed at US$0.60. The company has seen quarterly revenue move from US$1.20 billion in Q4 2024 to US$1.39 billion in Q4 2025, while basic EPS shifted from a loss of US$0.24 to a profit of US$0.54. This gives investors a clearer view of how margins are now...

Setting the scene on CVRx's latest results CVRx (CVRX) has reported third quarter FY 2025 revenue of US$14.7 million with a basic EPS loss of US$0.49, alongside trailing twelve month revenue of US$56.0 million and a basic EPS loss of US$2.02, giving investors a clear view of a company still in investment mode. The company has seen quarterly revenue move from US$11.8 million in Q2 2024 to US$14.7 million in Q3 2025. Quarterly basic EPS losses have ranged between US$0.43 and US$0.65 over the...

Rivian Automotive (RIVN) just closed out FY 2025 with fourth quarter revenue of US$1.3 billion, a basic EPS loss of US$0.66, and net income loss of US$811 million, setting the tone for how investors will read the full year. Over the past six quarters, revenue has moved between US$874 million in Q3 2024 and US$1.7 billion in Q4 2024, while quarterly basic EPS has ranged from a loss of US$0.48 in Q1 2025 to a loss of US$1.08 in Q3 2024. This highlights a business that is scaling the top line...

If you are wondering whether MillerKnoll at around US$21.78 still offers value or if the easy gains are gone, this article will explain what the current price reflects in more detail. The stock has shown a mixed pattern, with a 13.2% return over the last 30 days and 19.3% year to date, but a 3.4% decline over the past week and a 32.0% decline over five years that some investors may still have in mind. Recent coverage has focused on how MillerKnoll fits into the commercial services and office...

How Fortune Brands Innovations' FY 2025 Numbers Stack Up Against the Story Fortune Brands Innovations (FBIN) just closed out FY 2025 with Q4 revenue of US$1,077.5 million and basic EPS of US$0.63, alongside net income of US$76.4 million, putting fresh numbers on the table for investors watching the story play out. The company has seen quarterly revenue range from US$1,033.1 million to US$1,203.3 million over the year, while basic EPS moved between US$0.42 and US$0.83. This gives a clearer...

Federal Realty Investment Trust posts mixed FY 2025 finish as one off item weighs on FFO Federal Realty Investment Trust (FRT) has wrapped up FY 2025 with Q4 revenue of US$334.4 million, Basic EPS of US$1.50 and Funds From Operations of a US$465.1 million loss, while trailing twelve month revenue came in at about US$1.3 billion and Basic EPS at US$4.69. Over recent periods, revenue has moved from US$312.8 million in Q4 2024 to US$334.4 million in Q4 2025, while Basic EPS has shifted from...